Bipartisan industrial policy for the life sciences is needed in the U.S.

President Biden’s push to revitalize technology-based industries, focusing on semiconductors and electric vehicles, should also include the life sciences sector. This industry encompasses biotechnology, pharmaceuticals, medical devices, and more, competing globally with other nations investing heavily in their own industries. A bipartisan effort is needed to support a more active industrial policy in the life…

Read More

Study explores factors contributing to rural-urban difference in cervical cancer screening

A study on cervical cancer screening in rural and urban community health centers in the United States found that factors such as English proficiency, income, and area-level unemployment influence screening rates. During the COVID-19 pandemic, females at rural centers were less likely to be up-to-date with screening compared to urban centers. The difference was mainly…

Read More

How Your Sleep Affects Your Heart

Maintaining good sleep is just as essential for heart health as diet and exercise. Lack of sleep can increase the risk of obesity, heart disease, and type 2 diabetes. Sleep deprivation can also lead to weight gain, diabetes, and heart disease, as well as reduce life expectancy. Sleep apnea and chronic insomnia are linked to…

Read More

Reducing Alcohol Intake Tied to Fewer CV Events

A study found that reducing alcohol consumption from heavy to mild to moderate levels decreased the risk of major adverse cardiovascular events by 23%. Researchers analyzed data from over 21,000 adults in Korea with heavy alcohol intake and monitored changes in their drinking habits over two health examinations. Those who reduced drinking had a lower…

Read More

Gilead Sciences gets exclusive global license to develop, commercialize Xilio tumor-activated IL-12

Gilead Sciences has acquired an exclusive global license to develop and market Xilio’s tumor-activated IL-12 therapy. This partnership will allow Gilead to advance the development of this promising treatment for cancer. The agreement highlights Gilead’s commitment to expanding its portfolio of innovative therapies. The company’s use of cookies on its website for analytics and advertising…

Read More

The Skeleton in the Diet Closet: Why Quick-Fix Diets Like Keto Are Unrealistic, Impractical and Downright Discriminatory in the Workplace

Rising obesity rates and the popularity of quick weight loss methods like GLP-1s have led to a demand for easy ways to lose weight rapidly. However, traditional fad diets are not practical or sustainable, and can even be harmful to health. Restrictive diets can lead to yo-yo dieting, nutritional deficiencies, and other health risks. These…

Read More

Antibiotic-resistant infection tops assessment of national risks

The National Risk Assessment for Ireland 2023 has identified antimicrobial-resistant infections, a new pandemic, cyber-attacks, and disruptions to critical supply chains as the top risks facing the country. The report emphasizes the increasing levels of antimicrobial resistance, which make common infections more difficult to treat. The assessment also highlights the risk of a new pandemic,…

Read More

Bioretec receives FDA breakthrough device designation for spinal interbody cage

Bioretec received FDA breakthrough device designation for its RemeOs spinal interbody cage, designed to restore intervertebral height during cervical spinal fusion. Timo Lehtonen, CEO of Bioretec, expressed excitement about the market opportunities for the product, based on patented hybrid technology. This designation validates the company’s expertise in creating innovative orthopedic products to meet clinical needs….

Read More
error: Content is protected !!